AG
Artal Group’s Relay Therapeutics RLAY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-1,213,725
| Closed | -$15.2M | – | 112 |
|
2023
Q2 | $15.2M | Sell |
1,213,725
-460,018
| -27% | -$5.78M | 0.47% | 30 |
|
2023
Q1 | $27.6M | Buy |
1,673,743
+219,027
| +15% | +$3.61M | 1.64% | 17 |
|
2022
Q4 | $21.7M | Hold |
1,454,716
| – | – | 1.21% | 25 |
|
2022
Q3 | $32.5M | Buy |
1,454,716
+754,716
| +108% | +$16.9M | 1.39% | 22 |
|
2022
Q2 | $11.7M | Hold |
700,000
| – | – | 0.63% | 32 |
|
2022
Q1 | $21M | Sell |
700,000
-50,000
| -7% | -$1.5M | 0.88% | 24 |
|
2021
Q4 | $23M | Buy |
750,000
+350,000
| +88% | +$10.7M | 0.63% | 39 |
|
2021
Q3 | $12.6M | Hold |
400,000
| – | – | 0.28% | 65 |
|
2021
Q2 | $14.6M | Hold |
400,000
| – | – | 0.3% | 64 |
|
2021
Q1 | $13.8M | Hold |
400,000
| – | – | 0.24% | 71 |
|
2020
Q4 | $16.6M | Hold |
400,000
| – | – | 0.36% | 58 |
|
2020
Q3 | $17M | Buy |
+400,000
| New | +$17M | 0.41% | 43 |
|